Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells
Open Access
- 12 April 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-11
Abstract
Dysfunction of interleukin-10 producing regulatory B cells has been associated with the pathogenesis of autoimmune diseases, but whether regulatory B cells can be therapeutically induced in humans is currently unknown. Here we demonstrate that a subset of activated B cells expresses CD25, and the addition of low-dose recombinant IL-2 to in vitro stimulated peripheral blood and splenic human B cells augments IL-10 secretion. Administration of low dose IL-2, aldesleukin, to patients increases IL-10-producing B cells. Single-cell RNA sequencing of circulating immune cells isolated from low dose IL2-treated patients reveals an increase in plasmablast and plasma cell populations that are enriched for a regulatory B cell gene signature. The transcriptional repressorBACH2is significantly down-regulated in plasma cells from IL-2-treated patients, BACH2 binds to the IL-10 gene promoter, andBach2depletion or genetic deficiency increases B cell IL-10, implicating BACH2 suppression as an important mechanism by which IL-2 may promote an immunoregulatory phenotype in B cells.Keywords
Funding Information
- Academy of Medical Sciences
- DH | National Institute for Health Research (RP-2017-08-ST2-002)
This publication has 42 references indexed in Scilit:
- Bach2 maintains T cells in a naive state by suppressing effector memory-related genesProceedings of the National Academy of Sciences, 2013
- IgG4 production is confined to human IL-10–producing regulatory B cells that suppress antigen-specific immune responsesJournal of Allergy and Clinical Immunology, 2013
- HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent mannerProceedings of the National Academy of Sciences, 2013
- IL-2 Requirement for Human Plasma Cell Generation: Coupling Differentiation and Proliferation by Enhancing MAPK–ERK SignalingThe Journal of Immunology, 2012
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host DiseaseNew England Journal of Medicine, 2011
- Prevention of Arthritis by Interleukin 10–producing B CellsJournal of Experimental Medicine, 2003
- Human immune disorder arising from mutation of the α chain of the interleukin-2 receptorProceedings of the National Academy of Sciences, 1997
- Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartmentImmunity, 1995
- Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor βScience, 1995
- Ulcerative colitis-like disease in mice with a disrupted interleukin-2 geneCell, 1993